Lv61
1860 积分 2021-08-12 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
6小时前
待确认
How we prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies
9天前
已关闭
Musculoskeletal Imaging Findings of Hematologic Malignancies
1个月前
已完结
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study
3个月前
已完结
Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer
4个月前
已完结
The mechanisms and countermeasures for CAR-T cell expansion and persistence deficiency
4个月前
已完结
Overcoming solid-tumor barriers: armored CAR-T cell therapy
5个月前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
6个月前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
6个月前
已完结
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
6个月前
已完结
皖公网安备34019202002308
